Compare AUROW & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AUROW | TECH |
|---|---|---|
| Founded | 2017 | 1976 |
| Country | United States | United States |
| Employees | 1800 | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 10.1B |
| IPO Year | N/A | 1989 |
| Metric | AUROW | TECH |
|---|---|---|
| Price | $0.32 | $60.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $71.23 |
| AVG Volume (30 Days) | 137.0K | ★ 1.8M |
| Earning Date | 04-30-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 0.53% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.49 |
| Revenue | N/A | ★ $1,216,732,000.00 |
| Revenue This Year | N/A | $2.33 |
| Revenue Next Year | N/A | $7.05 |
| P/E Ratio | ★ N/A | $123.86 |
| Revenue Growth | N/A | ★ 3.85 |
| 52 Week Low | $2.09 | $46.01 |
| 52 Week High | $3.00 | $79.28 |
| Indicator | AUROW | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 45.72 | 45.33 |
| Support Level | $0.25 | $61.27 |
| Resistance Level | $0.39 | $63.98 |
| Average True Range (ATR) | 0.04 | 2.03 |
| MACD | 0.02 | -0.13 |
| Stochastic Oscillator | 52.67 | 35.03 |
Aurora Innovation Inc delivers self-driving technology safely, quickly, and broadly. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles. It underpins Aurora Horizon and Aurora Connect, its driver-as-a-service products for trucking and ride-hailing. The Company is developing the Aurora Driver, a scalable suite of self-driving hardware, software, and data services designed as a platform to adapt and interoperate among vehicle types and applications.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.